May 18, 2018 / 1:01 PM / 5 months ago

BRIEF-Valeritas Announces Positive Results From Studies Testing Co's Insulin Delivery Device

May 18 (Reuters) - Valeritas Holdings Inc:

* VALERITAS ANNOUNCES POSITIVE CLINICAL RESULTS ACROSS TWO NEW STUDIES EVALUATING V-GO® WEARABLE INSULIN DELIVERY DEVICE IN PATIENTS WITH TYPE 2 DIABETES

* VALERITAS HOLDINGS - IN TRIAL, AFTER THREE MONTHS OF V-GO USE, SIGNIFICANT REDUCTIONS WERE OBSERVED IN BOTH A1C AND TDD

* VALERITAS HOLDINGS INC - IMPROVEMENTS IN A1C WERE NOTED ACROSS A WIDE RANGE OF BASELINE INSULIN DOSES IN TRIAL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below